The role of EphA2 in sustaining neoangiogenesis was also reported in ovarian carcinoma, where EphA2 was associated with high expression of vascular endothelial growth factor (VEGF-a) and vascular endothelial cadherin (VE-cadherin) upregulation at both mRNA and protein levels [70]. Here, CDH5 is linked to ovarian carcinoma.